First Stoping Operations at Perseus Mining's CMA Underground

Elanco's Negasunt™ Powder (Coumaphos, Propoxur, Sulfanilamide Topical Powder) and Tanidil™ (Coumaphos, Propoxur) Receive Emergency Authorization for Use Against New World Screwworm in Livestock

Sally Beauty Holdings Announces Conference Call and Webcast to Discuss Second Quarter Financial Results on May 11, 2026

CBRE Group, Inc. Announces Pricing of $750 Million Senior Notes due 2036

LifeStance Health Group Set to Join S&P SmallCap 600

Bladex announces Net Profit of $56.4 Million for the First Quarter 2026

BLADEX ANNOUNCES QUARTERLY DIVIDEND PAYMENT FOR FIRST QUARTER 2026

ORVANA REPORTS Q2 FY2026 EXPLORATION RESULTS IN SPAIN

NOV Reports First Quarter 2026 Earnings

Irenic Acquisition Corp. Announces Pricing of $220,000,000 Initial Public Offering

Turning Point Brands to Host Q1 2026 Conference Call

Performance Shipping Inc. Announces Filing of 2025 Annual Report on Form 20-F

Biomea Fusion Announces Positive 52-Week Results from Phase 2 COVALENT-112 Trial in Type 1 Diabetes Showing C-Peptide Improvement and Durability Following 12-Weeks of Icovamenib Treatment

Veradermics Announces Launch of Public Offering

New Jersey American Water Proudly Recognizes American Water Charitable Foundation 2026 Water and Environment Grantees

Taysha Gene Therapies to Present New Preclinical Data Supporting Construct Design of TSHA-102 for Rett Syndrome at the ASGCT 2026 Annual Meeting

37 Capital Adopts Semi-Annual Financial Reporting

Lexeo Therapeutics Announces Multiple Presentations at the 29th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

Crinetics Pharmaceuticals Announces the European Commission Approval of PALSONIFY® (Paltusotine) for the Treatment of Acromegaly in Adults

Brown & Brown, Inc. announces first quarter 2026 results, including total revenues of $1.9 billion, an increase of 35.4%; flat Organic Revenue; growth of Organic Revenue with Contingents of 2.2%; diluted net income per share of $1.06; Diluted Net Income Per Share - Adjusted of $1.39; and a quarterly dividend of $0.165 per share